Andrew Callos
Corporate Officer/Principal bij CYTOKINETICS, INCORPORATED
Vermogen: 4 M $ op 30-04-2024
Profiel
Mr. Andrew Callos is a Chief Commercial Officer & Executive VP at Cytokinetics, Inc. Mr. Callos was previously employed as a Vice President-US Cardiology & Metabolic Marketing by Pfizer Inc. and an Assistant Vice President-Marketing by Wyeth Pharmaceuticals, Inc. He received his undergraduate degree from Drexel University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-03-2024 | 63 887 ( 0.06% ) | 4 M $ | 30-04-2024 |
Actieve functies van Andrew Callos
| Bedrijven | Functie | Begin |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01-03-2021 |
Eerdere bekende functies van Andrew Callos
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Verkoop & Marketing | - |
Opleiding van Andrew Callos
| Drexel University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |
